A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

Little information has emerged about osavampator, a potentially first-in-class drug, since its promising Phase II performance last spring.

( MENAFN - EIN Presswire) Spravato® (esketamine) has been approved for use as a standalone treatment for depression, without the requirement of an accompanying antidepressant. Rachel Norris, MD ...

Patrick Trucchio, an analyst from H.C. Wainwright, reiterated the Buy rating on Mind Medicine (MNMD – Research Report). The associated price ...

A team of US-based scientists have found "a probable causal connection" between a form of bacteria found in the human gut and the onset of depression.Carried out by a team from Harvard University and ...

Little did he know this downward spiral would continue, and in 2022 the situation was exacerbated when Kumar started to have ...

Explore how political divisiveness impacts mental health and amplifies high-functioning depression, and discover strategies ...

Hers breaks down the winter blues, what causes them, and research-backed tips for handling this seasonal mood change.

Sarah Chihaya’s unconventional memoir charts her troubled relationship with the literature that formed her.

Mind Medicine (MindMed) has dosed the first subject in the Phase III Panorama study of a proprietary form of lysergide ...

A three-judge panel decided Friday to commit Naomi Bell's to psychiatric care for 20 years for killing her daughter and ...

The FDA approves AXSM's Symbravo for the acute treatment of migraine with or without aura in adults. The latest nod diversifies its commercial portfolio.